On the basis of evidence that within the adult kidney, the aldo-keto reductase AKR1B7 (aldo-keto reductase family 1, member 7, also known as mouse vas deferens protein, MVDP) is selectively expressed in renin-producing cells, we aimed to define a possible role of AKR1B7 for the regulation and function of renin cells in the kidney. We could confirm colocalization and corecruitment of renin and of AKR1B7 in wild-type kidneys. Renin cells in AKR1B7-deficient kidneys showed normal morphology, numbers, and intrarenal distribution. Plasma renin concentration (PRC) and renin mRNA levels of AKR1B7-deficient mice were normal at standard chow and were lowered by a high-salt diet directly comparable to wild-type mice. Treatment with a low-salt diet in combination with an angiotensin-converting enzyme inhibitor strongly increased PRC and renin mRNA in a similar fashion both in AKR1B7-deficient and wild-type mice. Under this condition, we also observed a strong retrograde recruitment of renin-expressing cell along the preglomerular vessels, however, without a difference between AKR1B7-deficient and wild-type mice. The isolated perfused mouse kidney model was used to study the acute regulation of renin secretion by ANG II and by perfusion pressure. Regarding these parameters, no differences were observed between AKR1B7-deficient and wild-type kidneys. In summary, our data suggest that AKR1B7 is not of major relevance for the regulation of renin production and secretion in spite of its striking coregulation with renin expression. renin; AKR1B7; JG cell marker; aldo-keto reductase THE ALDO-KETO REDUCTASES (AKRs) form a superfamily of enzymes characterized by their common reaction mechanism of NADPH-dependent oxidoreduction of carbonyl groups (16). On
cells and Leydig cells in the testis (2, 5, 11, 24) . In the developing kidney the Akr1b7 gene is expressed similarly to the renin gene in mural cells of the preglomerular vasculature, in mesangial cells, and in collecting duct cells (8) . The transcriptional control of both genes is crucially established by the cAMP-signaling pathway (2, 10, 29) . Finally, metaplastic transformation of preglomerular vascular smooth muscle cells into renin-expressing cells, which occurs during chronic challenge of the renin-angiotensin-system, is associated with expression of AKR1B7 (8) . Evidence has been provided that the programming of the cells into renin-producing cells, but not the expression of renin per se, is relevant for AKR1B7 expression in the kidney (8) . If AKR1B7 plays a possible role in the major function of renin cells, namely, the production, processing, storage, and release of renin into the circulation is yet unknown. The function of AKR1B7, in general, is poorly understood. It has been shown recently that there is a functional cellular coupling between AKR1B7 and cyclooxygenase 2 (COX2) that catalyzes the first two steps in the generation of prostaglandins (23) . In turn, it is well known that COX2 is involved in the macula densa-controlled regulation of renin expression and secretion (18, 37) . A functional role in the formation of prostaglandin F 2␣ (PGF 2␣ ) has previously been suggested for AKR1B7 (17, 23) . Therefore, one could speculate about an impact of AKR1B7 on the renin system through potential PGF 2␣ synthesis. In fact, in vivo data suggest that PGF 2␣ could exert a stimulatory role for renin secretion (14, 36, 40) . We were, therefore, interested to define the role of AKR1B7 for the function of renin cells by studying AKR1B7-deficient mice. In view of the expression of AKR1B7 in blood vessels and glomerular mesangium during kidney development (8), we were also interested to see whether the genetic deletion of AKR1B7 leads to alterations of vessel and glomerulus formation.
MATERIALS AND METHODS
Animals. Akr1b7-/-mice were generated and provided by Theuring and colleagues (6) . Wild-type mice (WT) were obtained from the F2 generations of Akr1b7-/-and C57/BL6 breedings. Genotyping was performed by PCR on DNA isolated from tail biopsies (forward: 5=-tgcctcagcctc tcaca-3=; reverse 1: 5=-gcagggcccataacttg-3=; reverse 2: 5=-ttgggagaagaaaacatacact-3= WT 400 bp; knock out, KO, 700 bp). Aldosterone synthase-deficient mice (AS-/-) (25) were provided by O. Smithies (University of North Carolina, Chapel Hill, NC). Connexin 40-deficient mice (Cx40-/-) (19) were provided by K. Willecke (University of Bonn, Bonn, Germany). All experiments were performed on 8 -12-wk-old male mice and age-matched controls. Animals were kept on standard rodent chow (Ssniff, Soest, Germany) with free access to tap water. All experiments were conducted, according to the National Institutes of Health guidelines for care and use of animals in research. The experiments were approved by the local ethics committee and government.
In vivo experiments. WT and Akr1b7-/-mice were treated for 10 days with either a high-salt diet (4% wt/wt NaCl; Ssniff) or a low-salt diet (0.02% wt/wt NaCl; Ssniff) in combination with the ACEinhibitor enalapril. For the last 7 days of the low-salt diet, mice received enalapril (10 mg·kg Ϫ1 ·day Ϫ1 ; Sigma-Aldrich, St. Louis, MO) in the drinking water. Controls were maintained on standard rodent chow (0.4% wt/wt NaCl; Ssniff).
Blood pressure measurement. For noninvasive determination of systolic blood pressure, a tail-cuff manometry system was used (TSE Systems, Heidelberg, Germany). After a training period of seven consecutive days, in which conscious mice were placed into a heated (37°C) holding device for 15 min/day, the values of 10 days were considered for analysis.
Sample collection and mRNA analysis. Mice were anesthetized with an intraperitoneal injection of 12 mg/kg xylazine (Serumwerk, Bernburg, Germany) and 80 mg/kg ketamine (Bela-Pharm, Vechta, Germany). After ligation of the left renal artery, the kidney was excised, frozen in liquid N 2, and stored for mRNA analysis. Total RNA was isolated from frozen kidneys and cDNA synthesis, and mRNA determination was conducted, as described previously (30) . The following primers were used: renin forward: 5=-gaaggagagcaaaaggtaagag-3=; reverse: 5=-gtagtagaagggggagttgtg-3=; GAPDH forward: 5=-atgccatcactgccacccagaag-3=; reverse: 5=-acttggcaggtttctccaggcgg-3=; Akr1b3 forward: 5=-tcaacaacggcaccaaga-3=; reverse: 5=-gccacttgaggaggagca-3= (4); Akr1b7 forward: 5=-ccactggccacagggatt-3=; reverse: 5=-tttgcctttattgtctttgggtaa-3= (33); Akr1b8 forward: 5=-tcagcccacgaggcttccttc-3=; reverse: 5=-ctccggagtcgcatttgctcgca-3=; Akr1b16 forward: 5=-aattagtgacaaacattgccc-3=; reverse: 5=-agatgcgcttgcctggaggaca-3= (32) .
For immunohistochemistry and three-dimensional reconstruction, the right kidney was perfusion fixed in situ with Bouin's fixative.
Immunohistochemistry and three-dimensional reconstruction. Fivemicrometer serial slices of perfusion-fixed paraffin-embedded kidneys were stained for renin and ␣-smooth muscle actin (␣-SMA), as described previously (26) . For AKR1B7 immunostaining, anti-AKR1B7 (sc-27763; Santa Cruz Biotechnology, Santa Cruz, CA) was used. After digitization of 80 -100 serial slices (Axiovert 200 ϩ AxioCam MRm; Zeiss, Oberkochen, Germany), data were imported into Amira 5.4.2 software (VSG, Berlin, Germany) for subsequent generation of aligned grayscale-stacks of renin and ␣-SMA. In a labeling step, kidney structures and renin-positive areas were rebuilt from the gray values of each data set. All shown surfaces are based upon these segments.
Isolated perfused mouse kidney model. Kidneys were perfused ex situ with a modified Krebs-Henseleit solution (35) supplemented with 6 g/100 ml BSA and human red blood cells (10% hematocrit) at a constant pressure of 90 mmHg, as described previously (34) . Stock solutions of ANG II or isoproterenol were dissolved in freshly prepared perfusate and infused into the arterial limb of the perfusion circuit. To lower the extracellular calcium concentration into the submicromolar range, EGTA (3.1 mM) was added to the perfusate. To assess the pressure control of renin secretion, perfusion pressure was stepwise changed in a pressure range between 40 and 140 mmHg, using an electronic feedback control system. Venous perfusate samples were taken every 2 min for analysis of renin secretion rate (RSR). RSR is denoted as perfusate flow (ml/g organ weight·min Ϫ1 ) multiplied by renin activity (ngANG I/ml·h Ϫ1 ) of the perfusate. Renin activity was measured as the generation of ANG I in presence of plasma from bilaterally nephrectomized rats, serving as excess of renin substrate. ANG I was determined by radioimmunoassay (RENCTK; DiaSorin, Germany).
Plasma renin concentration (PRC).
Plasma samples were incubated with an excess of renin substrate for 1.5 h. The produced ANG I (ng/ml·h Ϫ1 ) was determined by radioimmunoassay (RENCTK, DiaSorin, Germany).
Statistical analysis. All values are denoted as means Ϯ SE. Differences between experimental groups were analyzed by ANOVA and Bonferroni's adjustment for multiple comparisons. P Ͻ 0.05 was considered statistically significant.
RESULTS

Intrarenal distributions of AKR1B7 and of renin.
In wildtype mice kept on normal-salt diet, we found intrarenal colocalization of AKR1B7 and of renin within the afferent arteriole at the juxtaglomerular position. AKR1B7 and renin immunoreactivity were detectable within the same cuboid juxtaglomerular cells, which continued the media layer of smooth muscle cells in the walls of afferent arterioles at the entrance to the glomerular capillary network (Fig. 1, A and B) . Treatment of wild-type mice Fig. 1 . Triple immunostaining for aldo-keto reductase 1B7 (AKR1B7; red), renin (green), and ␣-smooth muscle actin (␣-SMA; blue) on wild-type (wt) kidney sections of mice on a normal-salt diet (A) and after treatment with low-salt in combination with enalapril (LS/E) for 10 days (C). G, glomeruli; aff. art., afferent arteriole. B and D: immunostaining for AKR1B7 alone.
with a low-salt diet in combination with the ANG I-converting enzyme inhibitor (ACE) enalapril for 10 days led to a strong retrograde recruitment of renin-expressing cells along the preglomerular vessels, which was mediated by a metaplastic transformation of vascular smooth muscle cells into renin-producing cells. In parallel, also AKR1B7 expression is recruited in the media layer of afferent arterioles more distal from the glomerular vascular poles (Fig. 1, C and D) . To obtain information about the AKR1B7 expression pattern in the walls of larger arterial vessels like interlobulary arteries, we then investigated kidney sections of AS-/-mice, which show a markedly increased intravascular and perivascular number of renin-producing cells (27) . In these mice, AKR1B7 expression was maintained in renin-producing cells within the juxtaglomerular apparatus and in most, but not all, renin-expressing cells associated with preglomerular vessels (Fig. 2, A and B) . To examine whether AKR1B7 expression coincides with the renin expression outside the vessel walls, we next studied a mouse model with ectopic renin-producing cells, such as the connexin 40 (Cx40)-deficient mouse. Deletion of Cx40 causes a displacement of renin-producing cells from the media layer of the vessels to the periglomerular mesangium (22) . AKR1B7 immunoreactivity was absent in these extravascular reninexpressing cells but was occasionally present in the media of afferent arterioles at the juxtaglomerular position (Fig. 2, C and  D) . In summary, AKR1B7 expression was only found in frequent association with vascular cells but not with extravascular nor ectopic renin-expressing cells.
To obtain information about the role of AKR1B7 for the function of renin-producing cells, we then analyzed mice lacking AKR1B7.
Architecture of preglomerular vessels in AKR1B7-deficient mice. In light of the expression of AKR1B7 in glomerular mesangium and renal arteries in the newborn kidney (8), we were interested to assess the consequences of the genetic deletion of Akr1b7 on the renal vascular development. As shown in Fig. 3 , C and G, the architecture of the preglomerular vessel tree of AKR1B7-deficient mice was very similar to that of wild-type mice. No disparity was found in length (WT: 93 Ϯ 5 m vs. Akr1b7-/-: 84 Ϯ 6 m) nor in diameter (WT: 20 Ϯ 1 m vs. Akr1b7-/-: 18 Ϯ 0.8 m) of cortical afferent arterioles in kidneys of AKR1B7-deficient and wild-type mice. Also, the number of afferent arterioles and glomeruli was not obviously altered between the two genotypes.
It is still unknown to what extent the function of AKR1B7 is relevant for the differentiation, localization, and function of reninproducing cells. Therefore, we studied the expression and secretion of renin and its regulation in AKR1B7-deficient mice.
Distribution of renin-producing cells in AKR1B7-deficient kidneys. Under standard conditions, renin cells in AKR1B7-deficient kidneys displayed normal morphology, number, and intrarenal localization. Cuboid renin-producing cells were located in the media layer of afferent arterioles at the juxtaglomerular poles of the glomeruli (Fig. 3, A, C, E, G) . Challenge of renin expression induced by treatment with a low-salt diet in combination with the ACE inhibitor enalapril induced a strong retrograde recruitment of renin-expressing cells along the preglomerular vessels, with no difference between AKR1B7-deficient and wild-type mice (Fig. 3, B, D, F, H) . Feeding a high-salt diet lowered the number of renin-expressing cells in AKR1B7-deficient and wild-type mice (not shown).
Renin mRNA, PRC, and blood pressure. Under standard conditions, kidney renin mRNA abundance in Akr1b7-/-mice was indifferent to measurements in wild-type controls (Fig. 4A ), as were plasma renin concentrations (Fig. 4B ). In line with these findings, also, the average systolic blood pressure, determined by tail-cuff measurements, was normal in Akr1b7-/-mice compared with wild-type mice (Akr1b7-/-: 124 Ϯ 3 mmHg vs. WT: 127 Ϯ 2 mmHg; Fig. 4C ). The increase in the number of renin-producing cells during stimulation of the renin system induced by cotreatment with low-salt and enalapril went in parallel with increased renin mRNA levels (WT: 7-fold vs. Akr1b7-/-: 6.6-fold; Fig. 4A ) and PRC (WT: 34-fold vs. Akr1b7-/-: 43-fold; Fig. 4B ) in a similar fashion in AKR1B7-deficient and wild-type mice. During high-salt treatment, renin mRNA abundance was lowered by 30% in Akr1b7-/-similar to wild-type mice (20%). Also PRC was diminished during a high-salt diet (47% vs. 57%; Fig. 4, A and B) .
Renin secretion from isolated kidneys. The isolated perfused mouse kidney model was used to study the acute regulation of renin secretion, considering the major determinants of the RAAS activity, such as sympathetic nervous output, ANG II and the perfusion pressure. Renin secretion from Akr1b7ϩ/ϩ and Akr1b7-/-kidneys was stimulated to a similar extent by the adrenergic ␤-receptor agonist isoproterenol (10 nmol/l) (WT: 373 Ϯ 50 ng ANG I /h·min Ϫ1 ·g Ϫ1 vs. Akr1b7-/-: 364 Ϯ 54 ng ANG I /h·min Ϫ1 ·g Ϫ1 , Fig. 5A ). The effect of ANG II on renin secretion was assessed by adding graded concentrations of ANG II to the perfusate, in the presence of 10 nmol/l isoproterenol. ANG II reduced renin secretion in a dose-dependent manner with a half-maximal inhibitory effect occurring at a concentration of around 0.03 nmol/l ANG II (Fig. 5A ). As shown in Fig. 5A , no clear differences in the dose-response curves were observed between Akr1b7-/-mice and controls. Also the dependency of renin secretion on the kidney perfusion pressure did not differ between the two genotypes. Renin secretion was typically related to perfusion pressure in an inverse fashion (Fig. 5B) . Akr1b enzyme expression in the mouse kidney. Since AKR1B7 does not play a role in the regulation of renin production, we next investigated whether other AKR enzymes of the subgroup AKR1B may be able to compensate for the lack of AKR1B7. Among AKR1B7, three further murine Akr1b have been characterized: Akr1b3, Akr1b8, and Akr1b16 (31). We measured semiquantitatively the mRNA abundance of these genes in WT and Akr1b7-/-mouse kidneys. Akr1b7 was detectable in WT mice but not in Akr1b7-/-mice. In both genotypes, Akr1b3, Akr1b8, and Akr1b16 mRNA was present, however, without any significant differences (data not shown).
DISCUSSION
AKR1B7 has been identified as a marker protein for reninproducing cells in the mouse kidney (8) . Evidence has already been provided that the expression of AKR1B7 is not dependent on the expression of renin (8), since AKR1B7 expression was maintained in animals with deletion of the renin gene. Whether AKR1B7 function is relevant for renin synthesis and renin secretion is still unknown, and therefore, we attempted to address this issue in this study with AKR1B7-deficient mice.
Our data confirm a previous report that AKR1B7 is expressed in the media layer of afferent arterioles at the entrance into the capillary network. There, we found a strict coexpression of AKR1B7 with renin, in accordance with the data of Brunskill et al. (8) . Moreover, we could confirm that AKR1B7 expression increases in normal mice in parallel with renin expression along the media layer of afferent arterioles in states of a challenged renin-angiotensin system (8) . The well-known phenomenon of a retrograde recruitment of renin-expressing cells is apparently associated with the induction of AKR1B7 expression in these cells. Coexpression of AKR1B7 with renin was also maintained in mice with genetically disrupted aldosterone synthesis, which showed a compensatory increase of renin-expressing cells (27) . In these mice, renin cells are often arranged as multilayers surrounding afferent arterioles and interlobular arteries. We also found AKR1B7 immunoreactivity in these cell multilayers, which, however, show less consistent colocalization with renin immunoreactivity, compared with cells of the inner media layer of the vessels. In ectopically located renin-expressing cells occurring in kidneys with defective function of connexin 40, no colocalization of AKR1B7 with renin was found. In summary, these findings would suggest that AKR1B7 marks a subset of renin-producing cells, namely, those that are located in the media layer of afferent arterioles, including their juxtaglomerular position, i.e., reninexpressing cells occurring in the normal kidney.
In AKR1B7-deficient mice, we found no renal structural abnormalities, including vascular structures, nor abnormal numbers or shapes of glomeruli. In contrast, other knockout models of the aldose reductase superfamily, like AKR1B3, have renal structural abnormalities and exhibit a defective urine concentration ability (1, 39) . So AKR1B3 appears to be more important for the kidney development than AKR1B7, which seems not to be essential for a full maturation of the vascular tree, in spite of expression of AKR1B7 in blood vessels during kidney development. This conclusion is in line with the study of Baumann et al. (6) reporting that Akr1b7 knockout mice have normal growth and development.
To investigate the impact of genetic deletion of AKR1B7 on renin expression and secretion, we characterized the renin system of AKR1B7-deficient mice. Our findings show that reninproducing cells displayed normal numbers and localization in these mice. Apparently, AKR1B7 is not required for renin cell localization and structure.
Also, for the renin gene regulation, AKR1B7 appears to be of no relevance. Our data indicate no differences in renal renin mRNA abundance comparing AKR1B7-deficient mice and controls, irrespective of the treatment the mice received to modulate renin gene expression. The effect of a low-salt diet plus ACEinhibition led to increased renin expression levels, and a high-salt diet decreased the mRNA abundance of both genotypes.
Similarly, AKR1B7 appears not to be important for the regulation of renin secretion in vivo and at the organ and cellular level. Thus, plasma renin concentrations were not different between AKR1B7-deficient mice and their wild-type controls. Renin secretion from AKR1B7-deficient kidneys was stimulated by ␤-adrenergic activation and was inhibited by ANG II, as done in wild-type kidneys. Moreover, the triggering of renin secretion by the renal perfusion was normal in the absence of AKR1B7.
Although there is no obvious functional interdependency between renin and AKR1B7, the question arises which mechanism could mediate this striking coregulation of expression of the two genes in the same cells. Much argues for the cAMP-signaling pathway as a common denominator of akr1b7 and of renin gene expression. It is known that in rodents, the akr1b7 gene expression is under control of the second messenger cyclic AMP (2, 3, 28, 38) . The cAMP pathway is also of critical importance for renin expression in vivo (10, 18, 29) and on the cellular level (12, 13, 20, 21) . One may consider this coregulation of the renin gene and the akr1b7 gene by the cAMP-signaling pathway in reninexpressing cells as indirect evidence that the (patho)physiological mechanisms leading to changes in the number of renin-expressing cells involve an activation or deactivation of the cAMP pathway, as already suggested previously (9) .
Among Akr1b7, three further murine Akr1b are characterized: Akr1b3, Akr1b8, and Akr1b16. All four genes are located on chromosome 6 (locus 6 B1). Their tandem arrangement suggests that these genes arise from an ancestral gene duplication event (31) . To exclude a compensatory upregulation of other Akr1b isoforms, we made up a mRNA expression profile of the four Akr1b. Except Akr1b7 mRNA in Akr1b7-/-, all investigated isoforms were expressed to the same extent in kidneys of both genotypes. Therefore, we conclude a compensatory effect regarding the other Akr1b isoforms to be less likely.
In summary, our findings confirm the coexpression of AKR1B7 and of renin in the adult mouse kidney. Our data further indicate that AKR1B7 is not required for normal regulation of renin gene expression and renin secretion, either after stimulated or suppressed RAAS. Along with the previous report (8) , which documented that renin expression is not essential for AKR1B7 expression, our findings suggest that the expression of both genes is cell specific, but is without functional interdependency.
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